Research and Development

The Research and Development team at Pulmatrix is dedicated to innovating and advancing inhaled therapies for respiratory conditions such as cystic fibrosis, COPD, and idiopathic pulmonary fibrosis. Led by the Director of Pharmaceutical Development, the team leverages cutting-edge scientific research and data analysis to develop, test, and optimize novel formulations and delivery methods, ensuring safe and effective treatments for patients. Collaborating closely, the Senior Scientist and Research Associate contribute to experimental design, data collection, and the progression of projects from concept to clinical evaluation.